Cassava Sciences, Inc. (SAVA) Financials
SAVA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 151.7 million | 14.2 million |
2023-09-30 | 172.5 million | 17.4 million |
2023-06-30 | 197.2 million | 17.9 million |
2023-03-31 | 218.1 million | 14.1 million |
SAVA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -22.4 million | 2.1 million |
2023-09-30 | -26.6 million | 949000 |
2023-06-30 | -19.9 million | 835000 |
2023-03-31 | -13.6 million | 673000 |
SAVA Net Income
No data available :(
SAVA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 121.1 million | - | - |
2023-09-30 | 142.4 million | - | - |
2023-06-30 | 168.4 million | - | - |
2023-03-31 | 187.5 million | - | - |
SAVA Shares Outstanding
SAVA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 41000 | 18.7 million | 4.1 million | 356000 |
2023-09-30 | 22000 | 23.6 million | 4.3 million | - |
2023-06-30 | 6000 | 25.0 million | 3.8 million | - |
2023-03-31 | 357000 | 22.1 million | 4.4 million | - |
SAVA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 2.3 million | 356000 |
2023-09-30 | - | 392000 |
2023-06-30 | - | 391000 |
2023-03-31 | - | 391000 |
SAVA
Price: $22.06
52 week price:
Earnings Per Share: -2.32 USD
P/E Ratio: -10.39
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 2.0 million
Market Capitalization: 983.8 million